{"name":"Revalesio Corporation","slug":"revalesio-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPMVhacVdwVHVVNkdIRXlrTmJCV0lRU3EzdlZLdHZZWlBJT0ZTbDVvNUR4Y3o3cmdGRmtnamhJZEdMc3lybEZteGdrT2pYZUJFYm1WMnoxSUt2ejFJbmU1aGtWd2YtLW9fNFlXU1RZZ3dRbER4bDdBTWJudGFOY3NuUGswcHNrSF80TE80b0Njd3NjTTNQSlFvWXo1V1pEVEQ5elBjYVl4TTZWWXhxbTFOLXBZVU5xaF9BZmNGU3RGVjVHM0V0VEUxMFI3M3g5M0ZhR3lVM19XNUp2VnpubjFOWnRzTzk4cGwwVzJGdFNiZ3pVOUFXLWtDZkx6TkI0clR0OVhKUTdMSFlRdUpKQ3MtY2FCSlV5Y1p3V0lZbjNKOTRQZHFqRXhXTEYzbHc1M3UtMnhIMzBvSUlPVURzcHg5N3BrS1VseUVaVkg5NVQ5TTVSUQ?oc=5","date":"2026-03-04","type":"regulatory","source":"Barchart.com","summary":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - ","headline":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQV19SSmJGenRyTUxPR0twOHlwei1YNTVYUWNYVi1NaGoxU3NpYUdLQjNpamFnR3lKN3JXelRkeHdFWWdDeGRHUkg4YmNkcHFjLWhUNDJlVW5fX0xtQW1VUnVVdHA0d1l2X3RhTDNmUHJqUl9UUTJqZEpBVzdhLTI5SEVsS3lsODNxUG04OWdfUDE4T0hvMk9xUkVqaVNPd0dSOTMxb3U4YTZXTEttQ280SXRvek1uekJfVmZLYTFJWERNYkhoX0hyaWxHMm1Zcl9jcW1fekFyZ3I3MzNWbjlFVThCZG5aMHNDV1I3czZyZ19QZGR2cmlaNXJFSE9KVV9TejdEYXZaUEN3S1ZMNkNnR0JLSnFabXJMY3RIZmttTWx1MXVmZ0hLS0MwdE9aU2lxR2ZwajlqMG9mRzhFSEgwUw?oc=5","date":"2025-12-09","type":"pipeline","source":"prnewswire.com","summary":"Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight - prnewswire.com","headline":"Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxPblFoOTJ1X1VaRGpwQ1Rud2E2WERxRjQ2aWYwTVN6Nk9oY1k3YWZfR2tyZGN6WmFrRm1pdGtKSk1qUEFSMWZoaHVmMmllcFBkY1dnUlotUnZHUnY0dFVha25mMHA5NDZnWnR3eTBpV0ZPamo4c1pxS1hNcHIwVUdIYzhUVFRGZDBOYnJYcnp3WlBqSEFYYVhBU3RqZjBJXzFXMGt6b2s2bGkwVTlXN29VbzlTQm5pRDNNSzg0Sjd6N19CU0dNM0doZldoZnJ5OWpZcE10cnJDV3ZNZVpxTGdVeHJabURPbmtKbWhaVS1kdHp3Rk1QQ3hrX3dIc1U0WFV3ZTRObU5mRTIyS1hP?oc=5","date":"2025-10-21","type":"pipeline","source":"prnewswire.com","summary":"Revalesio to Present RNS60 - prnewswire.com","headline":"Revalesio to Present RNS60","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQMmREQmpUVHEyOFZDR2ZKc3Y2N0Z5VVVaRGJrdmJIX3JLekFiUmlCSld4WjJuN20zRWgzOWpZV2FBNE40dk1fQmFpT2VabDJ4ZFFoak1Zd0ZoVjI0cjQ3cEI0dDJ3d2w2RkZiUXpuX1hwMHp6Z1FTQURSYkFPY2Vic3JOSnIyeXZvNGwxQWVHVFc4Q3EzS0ZQQTNMUFB6cGVDSWVON1pIZFpJV0E5c2RTODdxNWVEQ1FlQ0xZT0xXVFZNV1dFZHdZYmxVX2dGcnBCZXhfMjVyN3lTQi1xOFcyclVUaDZ2REx5T3c?oc=5","date":"2025-07-31","type":"regulatory","source":"prnewswire.com","summary":"Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke - prnewswire.com","headline":"Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQYmtyV3JOSE1tU19HWE1HQzgwRVhwYkJNUG1iLS1lQmtONW9BNGhFWDFUNmJVVW1ObU5ZYjhBZHExaDg5bjdtZjRvbERUbFdwVWU2NFZNWDdxbG1VVnVtZzFZUTMwa3d5UkMxZndxYWE5dHpNanJwUi1uTThCei1QNDhmX0JPWHhONV90bmhSazMtX1lDb0pzN2NRbTBpaUVoRTVBYXg3YkZ3SHVlZnRIZXVaRUtDZGNmUFlpTkpVY0hSSF80RjhKMVFUTVctelBNMGEtZVJTbk40Z251Vy13akJRRktuNU5qN3BrdjZmVlFHVnl4YnFNQ251cmc1Z01ha1M0REdKX29rYU02dFE?oc=5","date":"2025-07-24","type":"pipeline","source":"PR Newswire UK","summary":"CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight - PR Newswire UK","headline":"CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxORndHY3daWUhJWEJGMnZieF93aEs4TW12UXkzV0QxVU1BR2NjZGtmVkhOV0lIZWw2a3o5Z1VMTW9DTnBJZUFIblRGMnJrUThVZk9Sa1Y1UnlIazhCTmx4RlpFTm1GLWNJXzNubGhWbldzQzFYcGN0MmhpZkItMXljYXNoV0RfZEJZeEx1MmxIcmZDd3VibllsOF9CZ0xYLV9ZR0d5U3F3TFRHMURrZmdZTWVzX0Jldkhyam5BVnR2V2h5eUxLbUJOTGxMQUpnb0s0TDBpVEV5Ni12eFQzc3o0R2hyVQ?oc=5","date":"2024-06-06","type":"pipeline","source":"prnewswire.com","summary":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight - prnewswire.com","headline":"Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSWdSOHBwaGwtdE80eUJ4cVJteEg0VHE4M3hCdzNxcG5rQ05ZRU9LeUJGMEw4WU9tMnp0VXFib3lpUmJLenNJTl9kY2h6ZkNLdlVHSUx4WkhLa1BOSEwxcU5qR1FndXhPeFlHVDVLZUVlZWdENUJPWmhJMzhRR1RVcVVEWjhJV1pUZ0VGa29ZUDd6NnJEUU1jcDdYaVdzZ0txWkJjVUxiNUkzZllsek9oTk00dGVSakVKemFDa0xodGh5aDlXQ2xma0l5UUZ4azM1dnlfSDFPVnV2ZnBaQmc?oc=5","date":"2024-06-04","type":"pipeline","source":"prnewswire.com","summary":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight - prnewswire.com","headline":"Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}